耶尔森氏菌诊断市场规模、份额和成长分析（按产品、诊断测试、技术、最终用户和地区划分）—2026-2033年产业预测

全球耶尔森氏菌诊断市场规模预计在 2024 年达到 36.2 亿美元，从 2025 年的 37.7 亿美元成长到 2033 年的 52.4 亿美元，在预测期（2026-2033 年）内复合年增长率为 4.2%。

全球耶尔森氏菌病诊断市场的主要驱动力是耶尔森氏菌感染疾病感染率的上升、诊断技术的进步以及人们对早期检测和治疗意识的提高。技术创新，尤其是分子诊断领域的创新，是推动市场成长的关键因素，同时加强食源性疾病的公共卫生教育也扮演了重要角色。耶尔森氏菌病病例数的增加也促进了市场扩张。然而，市场成长的潜在阻碍因素包括生产者之间日益激烈的竞争、政府医疗保健资金的限制以及机构的批量采购。该市场涵盖多个地区，其中北美、欧洲和亚太地区是主要贡献者，成熟企业和新兴企业均提供各种诊断产品和服务。政府对医疗保健基础设施的倡议和投资预计将推动未来的成长。

推动全球耶尔森氏菌诊断市场发展的因素

全球耶尔森菌诊断市场的主要驱动因素之一是耶尔森菌感染疾病的日益流行，尤其是鼠疫耶尔森菌（鼠疫的病原体）和肠炎耶尔森菌（肠胃炎的主要病原体）。感染率的上升（通常与环境因素、旅行和都市化有关）推动了对准确快速诊断检测的需求。此外，人们对通用感染疾病的认识不断提高，以及早期检测在控制感染传播方面的重要性，正在推动对先进诊断工具研发的投资，最终促进市场成长并加强公共卫生应对机制。

全球耶尔森氏菌诊断市场限制因素

全球耶尔森氏菌诊断市场的主要限制因素之一是医护人员和大众对耶尔森氏感染疾病的认知和了解有限。这种知识差距会导致误诊和延误诊断，从而阻碍对精准诊断工具的需求。此外，许多地区耶尔森氏菌感染疾病的盛行率相对较低，导致缺乏资金和研发倡议来开发先进的诊断解决方案，进一步阻碍了市场成长。因此，大众对耶尔森氏菌相关健康问题的认识不足和重视程度不够，为这个专业细分市场的製造商和相关人员带来了挑战。

全球耶尔森氏菌诊断市场趋势

全球耶尔森氏菌诊断市场正经历着向分子诊断技术的显着转变。其特点是聚合酵素链锁反应(PCR) 检测和核酸增幅检查(NAAT) 等创新技术的日益普及，这些技术能够有效检测耶尔森氏菌。与传统的培养方法相比，这些先进的分子方法因其更高的灵敏度和特异性以及更快的检测速度而备受青睐。直接从临床检体中识别耶尔森氏菌 DNA 的能力实现了快速且准确的诊断，促使医疗机构和实验室加强对分子诊断平台和检测方法的投资。这推动了该细分市场的强劲成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 技术进步

全球耶尔森氏菌诊断市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 装置
• 试剂盒和试剂

全球耶尔森氏菌诊断市场规模（按诊断测试和复合年增长率划分）（2026-2033 年）

• 粪便培养
• 影像检查
• 血清学检测
• 大肠镜检查
• ELISA
• 免疫测量
• 管内聚集法
• 电脑断层扫描
• 超音波
• 大肠镜检查
• 其他的

全球耶尔森氏菌诊断市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 免疫检测
• DNA探针
• 聚合酵素链锁反应（PCR）
• 流式细胞技术
• 层析法
• 其他的

全球耶尔森氏菌诊断市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

• 医院
• 公共卫生研究所
• 私人考试机构
• 其他的

全球耶尔森氏菌诊断市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Abbott Laboratories（USA）
• Thermo Fisher Scientific（USA）
• Bio-Rad Laboratories（USA）
• Hologic, Inc.（USA）
• Becton, Dickinson and Company（BD）（USA）
• Danaher Corporation（USA）
• PerkinElmer, Inc.（USA）
• QIAGEN NV（Netherlands）
• F. Hoffmann-La Roche Ltd（Switzerland）
• Siemens Healthineers AG（Germany）
• bioMerieux SA（France）
• Merck KGaA（Germany）
• Lonza Group AG（Switzerland）
• Agilent Technologies, Inc.（USA）
• Illumina, Inc.（USA）
• bioAffinity Technologies, Inc.（USA）
• Gen-Probe Incorporated（USA）

结论与建议

Global Yersinia Diagnostics Market size was valued at USD 3.62 Billion in 2024 and is poised to grow from USD 3.77 Billion in 2025 to USD 5.24 Billion by 2033, growing at a CAGR of 4.2% during the forecast period (2026-2033).

The global Yersinia diagnostics market is primarily fueled by the rising incidence of Yersinia infections, advancements in diagnostic technology, and heightened awareness surrounding early detection and treatment. Technological innovations, particularly in molecular diagnostics, are key growth catalysts, alongside increased public health education on food-borne diseases. The escalating number of yersiniosis cases also contributes to market expansion. However, market growth faces potential restraints from heightened competition among producers, limited government healthcare funding, and bulk purchasing by organizations. The market spans across multiple regions, with North America, Europe, and Asia Pacific as significant contributors, featuring both established and emerging companies delivering diverse diagnostic products and services. Government initiatives and investments in healthcare infrastructure are expected to bolster future growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Yersinia Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Yersinia Diagnostics Market Segments Analysis

Global Yersinia Diagnostics Market is segmented by Product, Diagnostic Test, Technology, End User and region. Based on Product, the market is segmented into Instruments and Kits and Reagents. Based on Diagnostic Test, the market is segmented into Stool Culture, Imaging Tests, Serological Tests, Colonoscopy, ELISA, Radioimmunoassay, Tube Agglutination, CT Scan, Ultrasonography, Colonoscopy and Others. Based on Technology, the market is segmented into Immunoassay, DNA Probes, Polymerase Chain Reaction (PCR), Flow Cytometry, Chromatography and Others. Based on End User, the market is segmented into Hospitals, Public Health Laboratories, Commercial Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Yersinia Diagnostics Market

One of the key market drivers for the global Yersinia diagnostics market is the increasing prevalence of Yersinia infections, particularly Yersinia pestis, which is responsible for plague, and Yersinia enterocolitica, a leading cause of gastroenteritis. The rise in infection rates, often linked to environmental factors, travel, and urbanization, has heightened the need for accurate and rapid diagnostic tests. Additionally, the growing awareness of zoonotic diseases and the importance of early detection in controlling outbreaks are propelling investments in research and development of sophisticated diagnostic tools, ultimately driving market growth and enhancing public health response mechanisms.

Restraints in the Global Yersinia Diagnostics Market

One significant market restraint for the global Yersinia diagnostics market is the limited awareness and understanding of Yersinia infections among healthcare professionals and the general public. This knowledge gap can lead to misdiagnosis or delayed diagnosis, subsequently hindering the demand for accurate diagnostic tools. Additionally, the relatively low prevalence of Yersinia infections in many regions may result in insufficient funding and research initiatives aimed at developing advanced diagnostic solutions, further impeding market growth. As a result, the lack of visibility and urgency surrounding Yersinia-related health issues poses a challenge for manufacturers and stakeholders in this specialized market segment.

Market Trends of the Global Yersinia Diagnostics Market

The Global Yersinia Diagnostics market is witnessing a significant shift towards molecular diagnostics, characterized by the growing adoption of innovative techniques such as polymerase chain reaction (PCR) assays and nucleic acid amplification tests (NAATs) for effective Yersinia detection. These advanced molecular methods are favored for their superior sensitivity and specificity compared to traditional culture-based techniques, alongside their ability to deliver rapid turnaround times. The capability to directly identify Yersinia DNA from clinical samples facilitates prompt and accurate diagnoses, prompting healthcare providers and laboratories to invest more heavily in molecular diagnostic platforms and assays, thereby catalyzing robust market growth in this segment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement

Global Yersinia Diagnostics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Instruments
• Kits and Reagents

Global Yersinia Diagnostics Market Size by Diagnostic Test & CAGR (2026-2033)

• Market Overview
• Stool Culture
• Imaging Tests
• Serological Tests
• Colonoscopy
• ELISA
• Radioimmunoassay
• Tube Agglutination
• CT Scan
• Ultrasonography
• Colonoscopy
• Others

Global Yersinia Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Immunoassay
• DNA Probes
• Polymerase Chain Reaction (PCR)
• Flow Cytometry
• Chromatography
• Others

Global Yersinia Diagnostics Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Public Health Laboratories
• Commercial Laboratories
• Others

Global Yersinia Diagnostics Market Size & CAGR (2026-2033)

• North America (Product, Diagnostic Test, Technology, End User)
  • US
  • Canada
• Europe (Product, Diagnostic Test, Technology, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Diagnostic Test, Technology, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Diagnostic Test, Technology, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Diagnostic Test, Technology, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioAffinity Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gen-Probe Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations